戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                      MTAP encodes the enzyme methylthioadenosine phosphorylase, a key enzyme in the m
2 midine and of spermine and is metabolized by methylthioadenosine phosphorylase, an enzyme missing in
3                                              Methylthioadenosine phosphorylase, an essential enzyme f
4 ix metalloproteinase-1, histone deacetylase, methylthioadenosine phosphorylase, and vascular endothel
5 rolase, purine nucleoside phosphorylase, and methylthioadenosine phosphorylase are required for Nrk-i
6 s of PRMT5 inhibitors in targeted therapy of methylthioadenosine phosphorylase-deleted cancers are pa
7 ne or with methylthioadenosine inhibition (5-methylthioadenosine phosphorylase deletion), and murine
8                 The structure of 5'-deoxy-5'-methylthioadenosine phosphorylase from Sulfolobus solfat
9               Interestingly, deletion of the methylthioadenosine phosphorylase gene (MTAP) results in
10 so studied for co-deletion of the contiguous methylthioadenosine phosphorylase gene, and this was det
11 st identical with trimeric human 5'-deoxy-5'-methylthioadenosine phosphorylase (hMTAP).
12 cture of Sulfolobus solfataricus 5'-deoxy-5'-methylthioadenosine phosphorylase II (SsMTAPII) in compl
13 rexpression of metabolism-related gene MTAP (methylthioadenosine phosphorylase) in SSM resulted in re
14 lian purine nucleoside phosphorylase but not methylthioadenosine phosphorylase is responsible for mam
15                                  5'-Deoxy-5'-methylthioadenosine phosphorylase (methylthioadeno-sine:
16                                           5'-Methylthioadenosine phosphorylase (MTAP) and 5'-methylth
17 ticular, the gene for the enzyme 5'-deoxy-5'-methylthioadenosine phosphorylase (MTAP) and the genes o
18                                              Methylthioadenosine phosphorylase (MTAP) and the tumor s
19 d Ado cleavage activity was identified as 5'-methylthioadenosine phosphorylase (MTAP) based on its bi
20 yclin-dependent kinase inhibitor 2A (CDKN2A)/methylthioadenosine phosphorylase (MTAP) codeletion occu
21 ncies, we discovered that loss of the enzyme methylthioadenosine phosphorylase (MTAP) confers a selec
22 ethyltransferase 5 (PRMT5) in the context of methylthioadenosine phosphorylase (MTAP) deletion, seen
23                                Homozygous 5'-methylthioadenosine phosphorylase (MTAP) deletions occur
24                                      Loss of Methylthioadenosine Phosphorylase (MTAP) expression, via
25                                              Methylthioadenosine phosphorylase (MTAP) gene deletions
26                                    The human methylthioadenosine phosphorylase (MTAP) gene is located
27                                          The methylthioadenosine phosphorylase (MTAP) gene is located
28 ely 10-15% of human cancers, deletion of the methylthioadenosine phosphorylase (MTAP) gene results in
29 denosylmethionine (AdoMet) salvage enzyme 5'-methylthioadenosine phosphorylase (MTAP) has been implic
30                       Homozygous deletion of methylthioadenosine phosphorylase (MTAP) in cancers such
31                            The deficiency of methylthioadenosine phosphorylase (MTAP) in T-cell acute
32                                  Deletion of methylthioadenosine phosphorylase (MTAP) is a common gen
33                                            5-Methylthioadenosine phosphorylase (MTAP) is a key enzyme
34                                              Methylthioadenosine phosphorylase (MTAP) is a key enzyme
35                                        Human methylthioadenosine phosphorylase (MTAP) is a purine and
36                                              Methylthioadenosine phosphorylase (MTAP) is an important
37                                  5'-Deoxy-5'-methylthioadenosine phosphorylase (MTAP) is involved in
38 21 containing tumor suppressors CDKN2A/B and methylthioadenosine phosphorylase (MTAP) is one of the m
39 owed a selective antiproliferative effect on methylthioadenosine phosphorylase (MTAP) KO cells, both
40                       Homozygous deletion of methylthioadenosine phosphorylase (MTAP) occurs in ~10%-
41 ed purine metabolites of tumor cells lacking methylthioadenosine phosphorylase (MTAP), a common genet
42 ependent growth and defects in expression of methylthioadenosine phosphorylase (MTAP), a key enzyme i
43                                     Human 5'-methylthioadenosine phosphorylase (MTAP), a reported ant
44                                              Methylthioadenosine phosphorylase (MTAP), an enzyme esse
45                                              Methylthioadenosine phosphorylase (MTAP), an enzyme invo
46 r suppressor gene p16INK4A and deficiency of methylthioadenosine phosphorylase (MTAP), both located o
47  study how methionine salvage pathway enzyme methylthioadenosine phosphorylase (MTAP), frequently del
48                            The gene encoding methylthioadenosine phosphorylase (MTAP), the initial en
49              Prostate cancer (CaP) relies on methylthioadenosine phosphorylase (MTAP), the rate-limit
50 ADMe-ImmA) is an 86-pm inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP).
51 approximate the transition state of human 5'-methylthioadenosine phosphorylase (MTAP).
52 rget in tumor cells lacking expression of 5'-methylthioadenosine phosphorylase (MTAP).
53 p16INK4A (CDKN2A), and the housekeeping gene methylthioadenosine phosphorylase (MTAP).
54 avorably to pharmacological inhibition of 5'-methylthioadenosine phosphorylase (MTAP).
55 cterized terminal exons of the gene encoding methylthioadenosine phosphorylase, MTAP.
56                                    T. brucei methylthioadenosine phosphorylase (TbMTAP) was found to
57 nt plants that expressed either MTN or human methylthioadenosine phosphorylase (which metabolizes MTA